Platelet Rich Therapy for Facial Rejuvenation

To assess patient-reported satisfaction of using platelet rich therapy for facial
rejuvenation using a validated questionnaire (the FACE-Q scale). This is a prospective study
of patients who will undergo platelet-rich therapy for facial rejuvenation at NYU Langone
Medical Center. Platelet rich therapy (PRT) has been increasingly used for wound healing, fat
grafting, hemostasis as well as facial enhancement. PRT involves injection of patient's own
platelets and fibrin, and has evolved as a less invasive technique for facial rejuvenation
compared to more traditional techniques. However, while platelet rich therapy for facial
enrichment continues to gain popularity; little evidence exists to support its use in the
current literature. Therefore, this study sets out to determine patient satisfaction as well
as quality of life following PRT for facial rejuvenation. PRT has been previously used
successfully in facial plastic surgery and is being offered as an option as part of standard
of care for facial rejuvenation (Sclafani).

Subjects will be identified by the principal investigator as they present to the office for
facial rejuvenation and are interested in an alternative to soft tissue fillers. All such
patients will be given PRT as an alternative option for facial rejuvenation and any patient
who agrees to this therapy will be enrolled in the study. Subject enrollment will continue
until a total of 30 subjects are recruited.

Inclusion Criteria:

- Males and females

- Ages 21 - 80

- Patients of all racial and ethnic origins

- Patients of Dr. Hazen undergoing facial rejuvenation

Exclusion Criteria:

- Patients undergoing facial rejuvenation using other methods including botox
injections, chemical peels, face lifts and others.

- Patients using blood thinners that cannot be stopped

- Patients who have used aspirin within a week of the procedure date